Wall Street Reaffirms Confidence in Palantir Following Pullback

Palantir's robust Q4 earnings and record contract value lead to 'Buy' ratings from UBS and Rosenblatt, though premium valuation remains a key debate.

After a recent share price correction, Palantir is regaining favor among major Wall Street institutions. Two prominent firms issued bullish ratings in late February, highlighting the data analytics company's strategic position. This renewed optimism is rooted in strong financial performance, though valuation concerns persist in a challenging market.

Strong Quarterly Results Underpin the Case

The analyst upgrades did not emerge in a vacuum. They follow Palantir's robust fourth-quarter results for fiscal 2025, released in early February. The company reported revenue of $1.41 billion, a striking 70% increase year-over-year, with earnings per share of $0.25, slightly surpassing expectations. A key milestone was achieved in its U.S. operations, where quarterly revenue surpassed $1 billion for the first time, driven by significant growth across both commercial and government client segments.

Further bolstering the bullish narrative, Palantir recorded a Total Contract Value (TCV) of $4.3 billion for Q4, marking a quarterly record. The customer count also rose to 954, indicating successful client acquisition and expanded platform adoption. Management's forward guidance was also viewed as ambitious, projecting 2026 revenue of approximately $7.18 to $7.20 billion and forecasting U.S. commercial growth exceeding 115%.

Dual Analyst Upgrades Provide Tailwind

In the wake of the stock's decline, two influential research houses adopted positive stances. UBS raised its rating on Palantir shares from "Neutral" to "Buy," maintaining a $180 price target. The analysts argued that the valuation appears more attractive post-selloff, emphasizing the company's prime positioning in the high-demand sectors of artificial intelligence and data software.

Separately, Rosenblatt Securities initiated coverage with a "Buy" recommendation and a $150 price target. The firm characterized Palantir as an AI software provider with an unusually strong competitive moat. Rosenblatt cited a sustainable growth trajectory and operational leverage—the potential for revenue increases to disproportionately boost profits—as primary reasons for its optimism.

Valuation and Market Context Remain Key Hurdles

Despite the positive commentary, the central debate continues to revolve around Palantir's premium valuation. UBS indirectly acknowledged this, contending that the stock looks "very attractive" based on its own free-cash-flow model (50x the 2027 estimate). The firm also noted competitive risks from large cloud "hyperscalers," Databricks, and AI model providers, but stated recent checks revealed no materially new threats.

The broader market environment adds another layer of complexity. Even with supportive analyst notes, share price gains were tempered as major indices like the Nasdaq and S&P 500 were, according to Reuters, heading for their steepest monthly loss since March 2025. In such periods, investors typically grow wary of highly valued growth stocks.

The technical picture reflects this caution. While shares edged higher on Friday, they remained down significantly over a 30-day period (-11.88%) and continued to trade below both their 50-day and 200-day moving averages.

Looking ahead to March, the near-term direction for the stock will likely hinge on two factors: Palantir's ability to sustain the high growth rate and robust contract momentum from Q4 into subsequent quarters, and whether the tense broader market climate—including interest rate and inflation signals—creates more room for expensive software equities to rally.